Cargando…
Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor
Cetuximab, a chimeric monoclonal antibody developed for targeting the Epidermal Growth Factor Receptor (EGFR), has been intensively used to treat cancer patients with metastatic colorectal cancer and head and neck cancer. Intact immunoglobulin G (IgG) antibody like cetuximab, however, has some limit...
Autores principales: | Kim, Young Pil, Park, Dongsun, Kim, Jae Jin, Choi, Won-Jae, Lee, Sun Hee, Lee, Seo Yun, Kim, Soyeon, Chung, Jee Min, Jeon, Jinseon, Lee, Byoung Dae, Shin, Joo-Ho, Lee, Yun-il, Cho, Hyeseong, Lee, Jeong-Min, Kang, Ho Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249956/ https://www.ncbi.nlm.nih.gov/pubmed/25438047 http://dx.doi.org/10.1371/journal.pone.0113442 |
Ejemplares similares
-
Correction: Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor
Publicado: (2015) -
A Novel Reciprocal Crosstalk between RNF168 and PARP1 to Regulate DNA Repair Processes
por: Kim, Jae Jin, et al.
Publicado: (2018) -
Poly (ADP-ribose) in the pathogenesis of Parkinson's disease
por: Lee, Yunjong, et al.
Publicado: (2014) -
USP39 promotes non-homologous end-joining repair by poly(ADP-ribose)-induced liquid demixing
por: Kim, Jae Jin, et al.
Publicado: (2021) -
Change in perception of the quality of death in the intensive care unit by healthcare workers associated with the implementation of the “well-dying law”
por: Lee, Ye Jin, et al.
Publicado: (2022)